Alkananda Sahoo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alkananda Sahoo has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Barbara Lapinska
Department of General Dentistry, Medical University of Lodz, 251 Pomorska St., 92-213 Lodz, Poland
2 shared publications - Divya Gopinath
Basic Medical and Dental Sciences Department, College of Dentistry Ajman University Ajman UAE
2 shared publications - Neeta Mohanty
Siksha O Anusandhan University, Bhubaneswar, India
2 shared publications - Saurav Panda
Department of Periodontics, Institute of Dental Sciences, Siksha O Anusandhan University, Bhubaneswar 751003, India
2 shared publications - Swagatika Panda
Department of Oral and Maxillofacial Pathology and Microbiology, Institute of Dental Sciences, Siksha ‘O’ Anusandhan, deemed to be University, Bhubaneswar, India
2 shared publications - Anamika Rai
Department of Oral Medicine & Radiology, Institute of Dental Sciences, Siksha ‘O’ Anusandhan deemed to be University, Bhubaneswar, Odish, India
1 shared publication
Latest Publications
- Open Access
- 24 May 2024
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 14 (4) , 423-429
Tumor thickness and depth of invasion in squamous cell carcinoma of tongue as indicators of the loco-regional spread of the disease: A preliminary study
- 24 May 2024
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 14 (4) , 423-429
Open AccessTumor thickness and depth of invasion in squamous cell carcinoma of tongue as indicators of the loco-regional spread of the disease: A preliminary study
- Open Access
- 7 April 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (8) , 2753
Can Immunoexpression of Cancer Stem Cell Markers Prognosticate Tongue Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis
The objective was to evaluate the association of the immunoexpression of cancer stem cell (CSC) markers with clinicopathological and survival outcomes in tongue squamous cell carcinoma (TSCC) patients. This systematic review and meta-analysis [PROSPERO (CRD42021226791)] included observational studies that compared the association of clinicopathological and survival outcomes with CSC immunoexpression in TSCC patients. Pooled odds ratios (ORs) and hazard ratios (HRs) with 95% confidence intervals (CI) were used as outcome measures. Six studies identified the association with three surface markers (c-MET, STAT3, CD44) and four transcription markers (NANOG, OCT4, BMI, SOX2). The odds of early-stage presentation were 41% (OR = 0.59, 95% CI 0.42–0.83) and 75% (OR = 0.25; 95% CI 0.14–0.45) lower in CSC and SOX2 immuno-positive cases than immuno-negative cases, respectively. The odds of well-differentiated tumors in transcription marker immuno-positive cases were 45% lower compared to immuno-negative cases (OR = 0.55, 95% CI 0.32–0.96). The odds of positive lymph nodes were 2.01 times higher in CSC immuno-positive cases compared to immuno-negative cases (OR = 2.01, 95% CI 1.11–3.65). Mortality in immuno-positive cases was 121% higher than that in immuno-negative cases (HR = 2.21; 95% CI 1.16–4.21). Advanced tumor staging and grading, lymph node metastasis, and mortality were significantly associated with positive immunoexpression of CSC markers.
- 7 April 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (8) , 2753
Open AccessCan Immunoexpression of Cancer Stem Cell Markers Prognosticate Tongue Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis
The objective was to evaluate the association of the immunoexpression of cancer stem cell (CSC) markers with clinicopathological and survival outcomes in tongue squamous cell carcinoma (TSCC) patients. This systematic review and meta-analysis [PROSPERO (CRD42021226791)] included observational studies that compared the association of clinicopathological and survival outcomes with CSC immunoexpression in TSCC patients. Pooled odds ratios (ORs) and hazard ratios (HRs) with 95% confidence intervals (CI) were used as outcome measures. Six studies identified the association with three surface markers (c-MET, STAT3, CD44) and four transcription markers (NANOG, OCT4, BMI, SOX2). The odds of early-stage presentation were 41% (OR = 0.59, 95% CI 0.42–0.83) and 75% (OR = 0.25; 95% CI 0.14–0.45) lower in CSC and SOX2 immuno-positive cases than immuno-negative cases, respectively. The odds of well-differentiated tumors in transcription marker immuno-positive cases were 45% lower compared to immuno-negative cases (OR = 0.55, 95% CI 0.32–0.96). The odds of positive lymph nodes were 2.01 times higher in CSC immuno-positive cases compared to immuno-negative cases (OR = 2.01, 95% CI 1.11–3.65). Mortality in immuno-positive cases was 121% higher than that in immuno-negative cases (HR = 2.21; 95% CI 1.16–4.21). Advanced tumor staging and grading, lymph node metastasis, and mortality were significantly associated with positive immunoexpression of CSC markers.
- Open Access
Are Survival Outcomes Different for Young and Old Patients with Oral and Oropharyngeal Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis
This systematic review and meta-analysis aims to address whether age can be a determinant of overall survival (OS), disease-free survival (DFS), recurrence, distant metastasis (DM) and second primary (SP) in surgically treated oral and oropharyngeal squamous cell carcinoma (OOPSCC). A total of 4981 cases and 44254 controls from 25 comparative observational studies were included in the analysis. A significantly better OS (matched subgroup analysis: OR 1.64; 95% CI 1.31–2.04, overall analysis: OR 1.48; 95% CI 1.09–2.01) was observed in young patients compared to older adults, with heterogeneity ranging from moderate to severe. Worse DFS (unmatched subgroup analysis OR 0.43; 95% CI 0.27–0.68) was observed in young patients compared to older adults with minimal to moderate heterogeneity. The frequency of recurrence (OR 1.49; 95% CI 1.10–2.02) and DM (OR 1.83; 95% CI 1.10–3.03) was significantly higher in the young patients, as found in unmatched and matched subgroup analysis, with the least heterogeneities. Young age can be considered as an independent prognostic factor for recurrence and distant metastases in OOP-SCC. Larger and methodologically robust observational studies with longer follow-up are needed to establish the definitive role of age as an independent prognostic factor on OS and DFS in OOPSCC.
Open AccessAre Survival Outcomes Different for Young and Old Patients with Oral and Oropharyngeal Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis
This systematic review and meta-analysis aims to address whether age can be a determinant of overall survival (OS), disease-free survival (DFS), recurrence, distant metastasis (DM) and second primary (SP) in surgically treated oral and oropharyngeal squamous cell carcinoma (OOPSCC). A total of 4981 cases and 44254 controls from 25 comparative observational studies were included in the analysis. A significantly better OS (matched subgroup analysis: OR 1.64; 95% CI 1.31–2.04, overall analysis: OR 1.48; 95% CI 1.09–2.01) was observed in young patients compared to older adults, with heterogeneity ranging from moderate to severe. Worse DFS (unmatched subgroup analysis OR 0.43; 95% CI 0.27–0.68) was observed in young patients compared to older adults with minimal to moderate heterogeneity. The frequency of recurrence (OR 1.49; 95% CI 1.10–2.02) and DM (OR 1.83; 95% CI 1.10–3.03) was significantly higher in the young patients, as found in unmatched and matched subgroup analysis, with the least heterogeneities. Young age can be considered as an independent prognostic factor for recurrence and distant metastases in OOP-SCC. Larger and methodologically robust observational studies with longer follow-up are needed to establish the definitive role of age as an independent prognostic factor on OS and DFS in OOPSCC.
- 1 January 2019
- Published by Diva Enterprises Private Limited in Indian Journal of Public Health Research & Development
- Vol. 10 (11) , 1032-1036
Central Giant Cell Granuloma: Contradicting the Usual Picture
Jaffe in 1953 differentiated Central Giant Cell Granuloma (CGCG) from Giant Cell Tumor of bone. This intra-osseous lesion has been described by various authors'as a reactive lesion or as a developmental anomaly or as a non neo-plastic lesion. Though inflammation, haemorrhage, local trauma has been suggested as some of the aetiological factors but actual aetiology is still unclear. Genetic aetiology has also been hypothesized. Mandible is the common site of occurrence, frequently crossing the midline. Incidences in females are more and less than 30 is the age of occurrence. The clinical behaviour of CGCG ranges from a slow-growing asymptomatic swelling to an aggressive lesion with pain, local osteolysis, root resorption and tooth displacement. Most widely accepted treatment is surgery. Nonsurgical treatments with alpha-interferon, calcitonin and corticosteroids have been described and their benefits may be worthy of consideration. Contrary to the age, gender and site here we present a case of CGCG in a 52-year-old male patient presenting with a swelling in the right anterior maxilla.
- 1 January 2019
- Published by Diva Enterprises Private Limited in Indian Journal of Public Health Research & Development
- Vol. 10 (11) , 1032-1036
Central Giant Cell Granuloma: Contradicting the Usual Picture
Jaffe in 1953 differentiated Central Giant Cell Granuloma (CGCG) from Giant Cell Tumor of bone. This intra-osseous lesion has been described by various authors'as a reactive lesion or as a developmental anomaly or as a non neo-plastic lesion. Though inflammation, haemorrhage, local trauma has been suggested as some of the aetiological factors but actual aetiology is still unclear. Genetic aetiology has also been hypothesized. Mandible is the common site of occurrence, frequently crossing the midline. Incidences in females are more and less than 30 is the age of occurrence. The clinical behaviour of CGCG ranges from a slow-growing asymptomatic swelling to an aggressive lesion with pain, local osteolysis, root resorption and tooth displacement. Most widely accepted treatment is surgery. Nonsurgical treatments with alpha-interferon, calcitonin and corticosteroids have been described and their benefits may be worthy of consideration. Contrary to the age, gender and site here we present a case of CGCG in a 52-year-old male patient presenting with a swelling in the right anterior maxilla.